These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients. Enooku K; Tsutsumi T; Kondo M; Fujiwara N; Sasako T; Shibahara J; Kado A; Okushin K; Fujinaga H; Nakagomi R; Minami T; Sato M; Uchino K; Nakagawa H; Kondo Y; Asaoka Y; Tateishi R; Ueki K; Ikeda H; Yoshida H; Moriya K; Yotsuyanagi H; Kadowaki T; Koike K J Gastroenterol; 2020 Feb; 55(2):227-243. PubMed ID: 31602526 [TBL] [Abstract][Full Text] [Related]
50. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients. Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434 [TBL] [Abstract][Full Text] [Related]
51. Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins. Lucero D; Miksztowicz V; Gualano G; Longo C; Landeira G; Álvarez E; Zago V; Brites F; Berg G; Fassio E; Schreier L Clin Chim Acta; 2017 Oct; 473():1-8. PubMed ID: 28802640 [TBL] [Abstract][Full Text] [Related]
52. Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh. Alam S; Gupta UD; Alam M; Kabir J; Chowdhury ZR; Alam AK Indian J Gastroenterol; 2014 Sep; 33(5):452-7. PubMed ID: 25023045 [TBL] [Abstract][Full Text] [Related]
53. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Cassader M; Gambino R; Musso G; Depetris N; Mecca F; Cavallo-Perin P; Pacini G; Rizzetto M; Pagano G Lipids; 2001 Oct; 36(10):1117-24. PubMed ID: 11768156 [TBL] [Abstract][Full Text] [Related]
54. Fructose as a key player in the development of fatty liver disease. Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247 [TBL] [Abstract][Full Text] [Related]
55. Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration. Patel YA; Gifford EJ; Glass LM; McNeil R; Turner MJ; Han B; Provenzale D; Choi SS; Moylan CA; Hunt CM Aliment Pharmacol Ther; 2018 Jan; 47(2):268-278. PubMed ID: 29115682 [TBL] [Abstract][Full Text] [Related]
56. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116 [TBL] [Abstract][Full Text] [Related]
57. Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD. Caussy C; Hsu C; Singh S; Bassirian S; Kolar J; Faulkner C; Sinha N; Bettencourt R; Gara N; Valasek MA; Schnabl B; Richards L; Brenner DA; Hofmann AF; Loomba R Aliment Pharmacol Ther; 2019 Jan; 49(2):183-193. PubMed ID: 30506692 [TBL] [Abstract][Full Text] [Related]
58. Lipoprotein profile in patients who survive a stroke. Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499 [TBL] [Abstract][Full Text] [Related]
60. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]